(Q29036090)

27 March 2017

0 references

1 reference

13

Tania Kümpfel

1 reference

27 March 2017

2

Lisa Ann Gerdes

1 reference

27 March 2017

4

Birgit Ertl-Wagner

1 reference

27 March 2017

author name string

Melania Spadaro

1

1 reference

27 March 2017

Markus Krumbholz

3

1 reference

27 March 2017

Franziska Sabrina Thaler

5

1 reference

27 March 2017

Elisabeth Schuh

6

1 reference

27 March 2017

Imke Metz

7

1 reference

27 March 2017

Astrid Blaschek

8

1 reference

27 March 2017

Andrea Dick

9

1 reference

27 March 2017

Wolfgang Brück

10

1 reference

27 March 2017

Reinhard Hohlfeld

11

1 reference

27 March 2017

Edgar Meinl

12

1 reference

27 March 2017

publication date

30 June 2016

1 reference

Neurology(R) neuroimmunology & neuroinflammation

27 March 2017

published in

1 reference

27 March 2017

volume

3

1 reference

27 March 2017

issue

5

1 reference

27 March 2017

page(s)

e257

1 reference

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology

27 March 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

The spectrum of MOG autoantibody-associated demyelinating diseases

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Oligodendrocyte death results in immune-mediated CNS demyelination.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4949775

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

3 June 2018

1 reference

12 December 2020

Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases

1 reference

12 December 2020

Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system

1 reference

12 December 2020

Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases

1 reference

12 December 2020

10.1212/NXI.0000000000000257

Identifiers

DOI

2 references

27 March 2017

1 reference

1 reference

PubMed publication ID

27458601

1 reference